<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166664">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02123498</url>
  </required_header>
  <id_info>
    <org_study_id>ETDLPR2014</org_study_id>
    <nct_id>NCT02123498</nct_id>
  </id_info>
  <brief_title>The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux</brief_title>
  <acronym>ETDLPR</acronym>
  <official_title>The Study of the Diagnosis of Eustachian Tube Dysfunction (ETD): Identifying the Relationship of Ear Fullness to Laryngopharyngeal Reflux (LPR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the relationship between ear fullness, pressure,
      and/or pain and laryngopharyngeal reflux, in order to focus medical therapy and improve
      therapeutic outcomes in this patient population.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Evidence of laryngopharyngeal reflux in patients complaining of ear fullness/pressure/pain</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participants complaining of ear pain, ear fullness, or ear pain are diagnosed with laryngopharyngeal reflux via laryngoscope exam and measurement by diagnostic pH-probe test.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Eustachian Tube Dysfunction</condition>
  <condition>Laryngopharyngeal Reflux</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omeprazole</intervention_name>
    <description>40mg, to be taken once daily by mouth, 30-60 minutes before meals, for at least 6 weeks</description>
    <arm_group_label>Single Arm</arm_group_label>
    <other_name>Prilosec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ranitidine</intervention_name>
    <description>300mg, to be taken once daily by mouth, before bedtime, for at least 6 weeks</description>
    <arm_group_label>Single Arm</arm_group_label>
    <other_name>Zantac</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pantoprazole</intervention_name>
    <description>40mg, to be taken twice daily by mouth, 30-60 minutes before meals, for at least 6 weeks. (Alternative intervention if participant cannot tolerate omeprazole, is on an anticoagulant medication, or if on medication contraindicated for omeprazole and ranitidine)</description>
    <arm_group_label>Single Arm</arm_group_label>
    <other_name>Protonix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>24-Hour Diagnostic pH-Probe Test</intervention_name>
    <description>Participants will undergo a routine clinical 24-hour diagnostic pH-probe test to assess quantitative measures for laryngopharyngeal reflux.</description>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laryngoscopy</intervention_name>
    <description>Participants will undergo routine clinical laryngoscopy to assess presence of laryngopharyngeal reflux.</description>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  They complain of symptoms of ear fullness, ear pain, and/or ear pressure, either
             unilateral or bilateral

          -  They are willing to participate in the study.

          -  They are between the ages of 18 to 80

        Exclusion Criteria:

          -  They have had major ear surgery (not including tympanostomy tubes)

          -  They have a medical condition that is another possible etiology of ear pain or acid
             reflux and may require additional medical or surgical intervention such as: Acute or
             chronic otitis externa, Chronic otitis media, Temporomandibular joint dysfunction,
             Upper aerodigestive track neoplasm, History of head/neck radiation therapy.

          -  They are pregnant. Proton pump inhibitors are a Category C drug with unknown
             pregnancy risks.

          -  They do not wish to participate in the study

          -  They are &lt;18 or &gt;80.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen X Xu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Otolaryngology Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helen X Xu, MD</last_name>
    <phone>(909) 558-2782</phone>
    <email>hxxu@llu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jinwei Hu, MD</last_name>
    <phone>(909) 558-2782</phone>
    <email>jhu@llu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>11234 Anderson Street</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helen X Xu, MD</last_name>
      <phone>909-558-2782</phone>
      <phone_ext>24910</phone_ext>
      <email>hxxu@llu.edu</email>
    </contact>
    <investigator>
      <last_name>Helen X Xu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>1895 Orange Tree Lane, Suite 102</name>
      <address>
        <city>Redlands</city>
        <state>California</state>
        <zip>92374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Priya Krishna, MD</last_name>
      <phone>909-558-2600</phone>
      <phone_ext>88558</phone_ext>
      <email>pkrishna@llu.edu</email>
    </contact>
    <investigator>
      <last_name>Priya Krishna, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Barbero GJ. Gastroesophageal reflux and upper airway disease. Otolaryngol Clin North Am. 1996 Feb;29(1):27-38.</citation>
    <PMID>8834270</PMID>
  </reference>
  <reference>
    <citation>Crapko M, Kerschner JE, Syring M, Johnston N. Role of extra-esophageal reflux in chronic otitis media with effusion. Laryngoscope. 2007 Aug;117(8):1419-23.</citation>
    <PMID>17585281</PMID>
  </reference>
  <reference>
    <citation>Heavner SB, Hardy SM, White DR, Prazma J, Pillsbury HC 3rd. Transient inflammation and dysfunction of the eustachian tube secondary to multiple exposures of simulated gastroesophageal refluxant. Ann Otol Rhinol Laryngol. 2001 Oct;110(10):928-34.</citation>
    <PMID>11642425</PMID>
  </reference>
  <reference>
    <citation>Mims JW. The impact of extra-esophageal reflux upon diseases of the upper respiratory tract. Curr Opin Otolaryngol Head Neck Surg. 2008 Jun;16(3):242-6. doi: 10.1097/MOO.0b013e3282fdc3d6. Review.</citation>
    <PMID>18475079</PMID>
  </reference>
  <reference>
    <citation>Norman G, Llewellyn A, Harden M, Coatesworth A, Kimberling D, Schilder A, McDaid C. Systematic review of the limited evidence base for treatments of Eustachian tube dysfunction: a health technology assessment. Clin Otolaryngol. 2014 Feb;39(1):6-21. doi: 10.1111/coa.12220.</citation>
    <PMID>24438176</PMID>
  </reference>
  <reference>
    <citation>Schreiber S, Garten D, Sudhoff H. Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders. Eur Arch Otorhinolaryngol. 2009 Jan;266(1):17-24. doi: 10.1007/s00405-008-0770-1. Epub 2008 Aug 13. Review.</citation>
    <PMID>18704479</PMID>
  </reference>
  <reference>
    <citation>Yazici ZM, Sari M, Uneri C, Midi A, Tugtepe H. Histologic changes in eustachian tube mucosa of rats after exposure to gastric reflux. Laryngoscope. 2008 May;118(5):849-53. doi: 10.1097/MLG.0b013e318164d0c0.</citation>
    <PMID>18300701</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>April 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Helen Xu, MD</investigator_full_name>
    <investigator_title>Otologist</investigator_title>
  </responsible_party>
  <keyword>ear pressure</keyword>
  <keyword>ear fullness</keyword>
  <keyword>ear pain</keyword>
  <keyword>ETD</keyword>
  <keyword>laryngopharyngeal reflux</keyword>
  <keyword>LPR</keyword>
  <keyword>gastroesophageal reflux disease</keyword>
  <keyword>GERD</keyword>
  <keyword>nasopharyngeal reflux</keyword>
  <keyword>acid reflux</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Regurgitation, Gastric</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Omeprazole</mesh_term>
    <mesh_term>Ranitidine</mesh_term>
    <mesh_term>Ranitidine bismuth citrate</mesh_term>
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
